Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.22 USD | +1.90% | +14.00% | -14.00% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.00% | 2.53B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Transcript : Intellia Therapeutics, Inc., Q4 2021 Earnings Call, Feb 24, 2022